Clinical Quiz: Juvenile Idiopathic Arthritis Treatment Recommendations from 2021 ACR JIA Guidelines

In the final installment in a series of clinical quizzes based on the American College of Rheumatology’s 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis, we focus on treatment recommendations for pediatric patients with JIA from a clinician perspective while taking into account the individualized needs of the patient and their caregivers. These include updated recommendations for the initial treatment for systemic JIA, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and oral glucocorticoids, and the importance of shared decision-making during the treatment and management process.